Cancer Immunotherapy Market By Product (Cancer Vaccines, Oncolytic Viral Therapies, Monoclonal Antibodies and Immunomodulators) and Cancer Type (Pancreatic Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer and Head & Neck Cancer) - Global Industry Analysis And Forecast To 2025
Cancer Immunotherapy is a type of treatment that makes use of some parts of person’s immune system to fight the disease. Cancer Immunotherapy works in the following ways; one is stimulating the immune system to work smarter & harder to fight the cancer cells and the other way is providing man-made immune system components to immune system. Immunotherapy is also sometimes called as biotherapy or biologic therapy. Research for newer techniques to immune treatment is done for improving the impact on treatment of cancer in future. Cancer Immunotherapy use is growing owing to; ongoing research in the field of chemo immunotherapy, increasing number of cases related to cancer, technical development in the therapies for treatment, increase in the R&D for treatment of cancer, etc. Therefore, the Cancer Immunotherapy Market is anticipated to expand and has tremendous scope during the forecast period. The global Cancer Immunotherapy Market anticipated to flourish in the future by growing at a significantly higher CAGR.
The global Cancer Immunotherapy Market is based on segment, by Product the market is segmented into Cancer Vaccines, Oncolytic Viral Therapies, Monoclonal Antibodies and Immunomodulators, and by Cancer Type the market is segmented into Pancreatic Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer and Head & Neck Cancer.
Cancer Immunotherapy Market, By Product
Oncolytic Viral Therapies
Cancer Immunotherapy Market, By Cancer Type
Head & Neck Cancer
On a global front, the Cancer Immunotherapy Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Cancer Immunotherapy Market owing to high number of aged population, modern treatments available, increasing cases of disorders, etc.
Cancer Immunotherapy Market, By Region
Rest of Europe
Rest of Asia-Pacific
Rest of South America
Middle East and Africa
Rest of MEA
The leading players in the market are Pfizer Inc., Novartis AG, Amgen Inc., Merck and Co. Inc., AstraZeneca, Immunomedics Inc., F. Hoffmann La Roche Ltd., Eli Lilly and Company, Bayer AG, Bristol-Myers Squibb Company and Advaxis Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
Merck and Co. Inc.
F. Hoffmann La Roche Ltd.
Eli Lilly and Company
Bristol-Myers Squibb Company
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?